105 related articles for article (PubMed ID: 6200399)
21. Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 degrees C for 6 days.
Buchta C; Felfernig M; Höcker P; Macher M; Körmöczi GF; Quehenberger P; Heinzl H; Knöbl P
Vox Sang; 2004 Oct; 87(3):182-6. PubMed ID: 15569070
[TBL] [Abstract][Full Text] [Related]
22. Stability of Russell's viper venom toxoid (lyophilized form) on storage.
Aung W; Hlaing KK; Kyaw KP; Win MM; Kyaw A
Jpn J Infect Dis; 1999 Dec; 52(6):234-7. PubMed ID: 10738360
[TBL] [Abstract][Full Text] [Related]
23. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM
J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288
[TBL] [Abstract][Full Text] [Related]
24. Influence of fermentation time, cryoprotectant and neutralization of cell concentrate on freeze-drying survival, storage stability, and acid and bile exposure of Bifidobacterium animalis ssp. lactis cells produced without milk-based ingredients.
Saarela M; Virkajärvi I; Alakomi HL; Mattila-Sandholm T; Vaari A; Suomalainen T; Mättö J
J Appl Microbiol; 2005; 99(6):1330-9. PubMed ID: 16313405
[TBL] [Abstract][Full Text] [Related]
25. Stability of factor VIII concentrates after reconstitution.
Schulman S; Gitel S; Martinowitz U
Am J Hematol; 1994 Mar; 45(3):217-23. PubMed ID: 8296792
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics, thrombogenicity and safety of a double viral inactivated factor IX concentrate compared with a prothrombin complex concentrate.
Ruiz-Sáez A; Hong A; Arguello A; Echenagucia M; Boadas A; Fabbrizzi F; Minichilli F; Bosch NB
Haemophilia; 2005 Nov; 11(6):583-8. PubMed ID: 16236107
[TBL] [Abstract][Full Text] [Related]
27. Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems.
Dong WY; Körber M; López Esguerra V; Bodmeier R
J Control Release; 2006 Oct; 115(2):158-67. PubMed ID: 16963145
[TBL] [Abstract][Full Text] [Related]
28. Study of coagulation factor activities in apheresed thawed fresh frozen plasma at 1-6 degrees C for five days.
Sidhu RS; Le T; Brimhall B; Thompson H
J Clin Apher; 2006 Dec; 21(4):224-6. PubMed ID: 16607628
[TBL] [Abstract][Full Text] [Related]
29. A lyophilized formulation to extend the shelf-life of tuberculin PPD.
Bharnthong T; Prachayasittikul V; Isarankura Na Ayudhya C; Premchaiporn P; Khow O; Sitprija V
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):970-5. PubMed ID: 16295554
[TBL] [Abstract][Full Text] [Related]
30. Biochemical and in vivo properties of high purity factor IX concentrates.
Berntorp E; Björkman S; Carlsson M; Lethagen S; Nilsson IM
Thromb Haemost; 1993 Nov; 70(5):768-73. PubMed ID: 8128433
[TBL] [Abstract][Full Text] [Related]
31. Stability of reconstituted fluconazole oral suspension in plastic bottles and oral syringes.
Dentinger PJ; Swenson CF
Ann Pharmacother; 2009 Mar; 43(3):485-9. PubMed ID: 19208778
[TBL] [Abstract][Full Text] [Related]
32. Overcoming the need for a cold chain with conjugated meningococcal Group C vaccine: A controlled, randomized, double-blind study in toddlers on the safety and immunogenicity of Menjugate, stored at room temperature for 6 months.
Schöndorf I; Banzhoff A; Nicolay U; Diaz-Mitoma F
Vaccine; 2007 Jan; 25(7):1175-82. PubMed ID: 17095129
[TBL] [Abstract][Full Text] [Related]
33. The improved dissolution and prevention of ampoule breakage attained by the introduction of pretreatment into the production process of the lyophilized formulation of recombinant human Interleukin-11 (rhIL-11).
Hirakura Y; Kojima S; Okada A; Yokohama S; Yokota S
Int J Pharm; 2004 Nov; 286(1-2):53-67. PubMed ID: 15501002
[TBL] [Abstract][Full Text] [Related]
34. Radiochemical purity, at expiry, and radiochemical stability of iodine-131 labelled meta-iodobenzylguanidine concentrates for intravenous infusion.
Wafelman AR; Hoefnagel CA; Maes RA; Beijnen JH
Nuklearmedizin; 1996 Aug; 35(4):122-5. PubMed ID: 8784866
[TBL] [Abstract][Full Text] [Related]
35. Stabilization of a freeze-dried recombinant streptokinase formulation without serum albumin.
López M; González LR; Reyes N; Sotolongo J; Pujol V
J Clin Pharm Ther; 2004 Aug; 29(4):367-73. PubMed ID: 15271104
[TBL] [Abstract][Full Text] [Related]
36. [Changes in the blood coagulating properties of preserved blood and the native and lyophilized plasma of cattle during storage].
Khubenov KhD
Vet Med Nauki; 1984; 21(5):54-60. PubMed ID: 6474825
[TBL] [Abstract][Full Text] [Related]
37. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
Psathas PA; Kuzmission A; Ikeda K; Yasuo S
Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
[TBL] [Abstract][Full Text] [Related]
38. [Biochemical activity of lactic acid bacterial lyophilized concentrates obtained by continous cultivation].
Krasnikova LV; Silant'eva LA; Gorbatova KK; Vasil'ev NF
Prikl Biokhim Mikrobiol; 1978; 14(3):405-9. PubMed ID: 674117
[TBL] [Abstract][Full Text] [Related]
39. Preparation and heat-treatment of factor-IX-concentrates.
Stampe D; Wieland B; Köhle A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):523-7. PubMed ID: 2465966
[TBL] [Abstract][Full Text] [Related]
40. Compatibility of azathioprine sodium with intravenous fluids.
Johnson CA; Porter WA
Am J Hosp Pharm; 1981 Jun; 38(6):871-5. PubMed ID: 7246562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
